Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
2.990
-0.200 (-6.27%)
At close: Mar 20, 2026, 4:00 PM EDT
3.040
+0.050 (1.67%)
After-hours: Mar 20, 2026, 6:12 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $188.38 million as of March 20, 2026. Its market cap has increased by 248.68% in one year.
Market Cap
188.38M
Enterprise Value
102.95M
1-Year Change
248.68%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $188.38M, a decrease of -76.65%. That is a compound annual growth rate of -23.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 246.78M | 3.27% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 203.76M |
| SAB Biotherapeutics | 195.14M |
| Arcturus Therapeutics Holdings | 191.29M |
| Zentalis Pharmaceuticals | 188.57M |
| Caribou Biosciences | 187.48M |
| MacroGenics | 182.72M |
| Sutro Biopharma | 179.64M |
| Galectin Therapeutics | 179.56M |